Benzimidazoles for inhibiting protein tyrosine kinase mediated c

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514393, 5483021, 5483044, 5483047, A61K 31415, C07D23508

Patent

active

059901462

ABSTRACT:
Benzimidazoles of Formula I below are inhibitors of protein tyrosine kinases, and are useful in treating cellular proliferation. ##STR1## The compounds are especially useful in treating cancer, atherosclerosis, restenosis, and psoriasis.

REFERENCES:
patent: 3644382 (1972-02-01), Clemence et al.
patent: 4186135 (1980-01-01), Thominet et al.
patent: 4492708 (1985-01-01), Spitzer
patent: 5283242 (1994-02-01), Ellingboe
patent: 5360809 (1994-11-01), Axelsson et al.
patent: 5527548 (1996-06-01), Tyortyalian
patent: 5552426 (1996-09-01), Lunn et al.
patent: 5554632 (1996-09-01), Teuber et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Benzimidazoles for inhibiting protein tyrosine kinase mediated c does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Benzimidazoles for inhibiting protein tyrosine kinase mediated c, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzimidazoles for inhibiting protein tyrosine kinase mediated c will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1222421

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.